2-86106318-G-A
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_017952.6(PTCD3):c.71G>A(p.Arg24Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000461 in 1,614,068 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_017952.6 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
PTCD3 | NM_017952.6 | c.71G>A | p.Arg24Gln | missense_variant | 1/24 | ENST00000254630.12 | NP_060422.4 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
PTCD3 | ENST00000254630.12 | c.71G>A | p.Arg24Gln | missense_variant | 1/24 | 1 | NM_017952.6 | ENSP00000254630 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000269 AC: 41AN: 152188Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.000287 AC: 72AN: 250838Hom.: 1 AF XY: 0.000273 AC XY: 37AN XY: 135728
GnomAD4 exome AF: 0.000481 AC: 703AN: 1461762Hom.: 0 Cov.: 31 AF XY: 0.000443 AC XY: 322AN XY: 727188
GnomAD4 genome AF: 0.000269 AC: 41AN: 152306Hom.: 0 Cov.: 33 AF XY: 0.000175 AC XY: 13AN XY: 74478
ClinVar
Submissions by phenotype
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 15, 2022 | The c.71G>A (p.R24Q) alteration is located in exon 1 (coding exon 1) of the PTCD3 gene. This alteration results from a G to A substitution at nucleotide position 71, causing the arginine (R) at amino acid position 24 to be replaced by a glutamine (Q). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at